» Articles » PMID: 30759004

Bioactive Sphingolipids in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Overview
Specialty Pulmonary Medicine
Date 2019 Feb 14
PMID 30759004
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A better understanding of the pathogenesis of distinct chronic obstructive pulmonary disease (COPD) phenotypes will improve diagnostic and therapeutic options for this common disease. We present evidence that sphingolipids such as ceramides are involved in the emphysema pathogenesis. Whereas distinct ceramide species cause cell death by apoptosis and necroptosis, cell adaptation leads to accumulation of other sphingolipid metabolites that extend cell survival by triggering autophagy. Cigarette smoke-released sphingolipids have been involved in both the initiation and persistence of lung injury via intracellular signaling and paracrine effects mediated via exosomes and plasma membrane-bound microparticles. Strategies to control sphingolipid metabolite production may promote cellular repair and maintenance to treat COPD.

Citing Articles

The relationship between genetic prediction of 486 blood metabolites and the risk of COPD: mendelian randomization study.

Zhang Y, Ma X, Wu F, Sun Y, Mou H, Liu X Sci Rep. 2025; 15(1):7349.

PMID: 40025290 PMC: 11873255. DOI: 10.1038/s41598-025-92216-0.


Causal Effects of Gut Microbiota and Metabolites on Chronic Obstructive Pulmonary Disease: A Bidirectional Two Sample Mendelian Randomization Study.

Du Y, Wang S, Zhou T, Zhao Z Int J Chron Obstruct Pulmon Dis. 2024; 19:2153-2167.

PMID: 39360021 PMC: 11446199. DOI: 10.2147/COPD.S472218.


Metabolomics unveils the mechanism of Bufei Huayu decoction in combination with cisplatin against non-small cell lung cancer (NSCLC).

Feng Y, Jiang Y, Zhou Y, Li Z, Yang Q, Mo J Heliyon. 2023; 9(8):e19155.

PMID: 37664700 PMC: 10469573. DOI: 10.1016/j.heliyon.2023.e19155.


Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.

Staquicini D, Cardo-Vila M, Rotolo J, Staquicini F, Tang F, Smith T Proc Natl Acad Sci U S A. 2023; 120(34):e2220269120.

PMID: 37579172 PMC: 10450669. DOI: 10.1073/pnas.2220269120.


Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD.

Huang Q, Wang Y, Zhang L, Qian W, Shen S, Wang J Respir Res. 2022; 23(1):367.

PMID: 36539833 PMC: 9764587. DOI: 10.1186/s12931-022-02293-2.


References
1.
Diab K, Adamowicz J, Kamocki K, Rush N, Garrison J, Gu Y . Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. Am J Respir Crit Care Med. 2009; 181(4):344-52. PMC: 5455841. DOI: 10.1164/rccm.200906-0826OC. View

2.
Petrache I, Medler T, Richter A, Kamocki K, Chukwueke U, Zhen L . Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide. Am J Physiol Lung Cell Mol Physiol. 2008; 295(1):L44-53. PMC: 2494787. DOI: 10.1152/ajplung.00448.2007. View

3.
Suzuki M, Betsuyaku T, Nagai K, Fuke S, Nasuhara Y, Kaga K . Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and COPD patients. Inhal Toxicol. 2008; 20(3):349-59. DOI: 10.1080/08958370701866412. View

4.
Petrache I, Natarajan V, Zhen L, Medler T, Richter A, Cho C . Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med. 2005; 11(5):491-8. PMC: 1352344. DOI: 10.1038/nm1238. View

5.
Petrache I, Berdyshev E . Ceramide Signaling and Metabolism in Pathophysiological States of the Lung. Annu Rev Physiol. 2015; 78:463-80. DOI: 10.1146/annurev-physiol-021115-105221. View